Skip to main content
OpenTrials

Clinical trial condition

Hypochondroplasia

Explore clinical trials studying Hypochondroplasia. Study availability and eligibility vary by location and protocol.

12 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Hypochondroplasia trial results

Recruiting

Prospective Clinical Assessment Study in Children With Hypochondroplasia

NCT06410976

Conditions
Bone Diseases, Bone Diseases, Developmental, Carbohydrate Metabolism, Inborn Errors, +16 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
View all 25 locations
View Trial Details
Recruiting

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

NCT07126262

Conditions
Hypochondroplasia
Locations
  • Phoenix Children's Hospital - Thomas Campus (Main) Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Benioff Children's Hospital - Oakland Oakland, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 26 locations
View Trial Details
Recruiting

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

NCT06212947

Conditions
Hypochondroplasia
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Nemours Alfred I. Dupont Hospital for Children Wilmington, Delaware, United States
View all 43 locations
View Trial Details
Enrolling by Invitation

An Interventional Study of Infigratinib in Children With Hypochondroplasia

NCT06873035

Conditions
Bone Diseases, Bone Diseases, Developmental, Carbohydrate Metabolism, Inborn Errors, +16 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
View all 24 locations
View Trial Details
Enrolling by Invitation

Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia

NCT07393373

Conditions
Bone Diseases, Bone Diseases, Developmental, Carbohydrate Metabolism, Inborn Errors, +16 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
View all 24 locations
View Trial Details
Enrolling by Invitation

Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

NCT07073014

Conditions
Hypochondroplasia
Locations
  • Nemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children) Wilmington, Delaware, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View all 23 locations
View Trial Details
Completed

Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children

NCT01111019

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • Endocrinologie Pédiatrique - centre des maladies rares de la croissance -Hôpital Necker Enfants Malades Paris, France
View Trial Details

Related conditions